Literature DB >> 17266713

Role of Toll-like receptor 4 in innate immune responses in a mouse model of acute otitis media.

Takashi Hirano1, Satoru Kodama, Keigo Fujita, Kazuhiko Maeda, Masashi Suzuki.   

Abstract

Nontypeable Haemophilus influenzae (NTHi) is considered a major pathogen underlying middle ear infection. This study characterized the role of Toll-like receptor 4 in the innate immune responses to acute otitis media induced by NTHi in mice. We used C3H/HeJ mice, which have nonfunctional Toll-like receptor 4, and normal wild-type C3H/HeN mice. NTHi were injected into the tympanic bulla, and middle ear effusions and tissues were collected. In C3H/HeN mice, the severity of acute otitis media decreased promptly with a significant reduction in bacterial recovery from middle ear effusions 48 h after injection. In contrast, all C3H/HeJ mice had otitis media at all time points examined, and increasing bacterial counts from middle ear effusions were detected in C3H/HeJ mice 72 h after injection. Expression of intracellular adhesion molecule-1 by the middle ear mucosa paralleled the number of polymorphonuclear cells in the middle ear in both strains. The findings of transmission electron microscopy revealed that phagocytosis and phagosome maturation of polymorphonuclear cells was impaired in C3H/HeJ mice. Our findings indicate that Toll-like receptor 4 plays a part in the early accumulation and functional promotion of polymorphonuclear cells in the middle ear for eradicating NTHi infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17266713     DOI: 10.1111/j.1574-695X.2006.00186.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  19 in total

1.  The inflammasome adaptor ASC contributes to multiple innate immune processes in the resolution of otitis media.

Authors:  Arwa Kurabi; Jasmine Lee; Chelsea Wong; Kwang Pak; Hal M Hoffman; Allen F Ryan; Stephen I Wasserman
Journal:  Innate Immun       Date:  2014-03-20       Impact factor: 2.680

Review 2.  Role of innate immunity in the pathogenesis of otitis media.

Authors:  Rahul Mittal; Joyson Kodiyan; Robert Gerring; Kalai Mathee; Jian-Dong Li; M'hamed Grati; Xue Zhong Liu
Journal:  Int J Infect Dis       Date:  2014-11-05       Impact factor: 3.623

3.  Myeloid differentiation primary response gene 88 is required for the resolution of otitis media.

Authors:  Michelle Hernandez; Anke Leichtle; Kwang Pak; Joerg Ebmeyer; Sara Euteneuer; Marygorret Obonyo; Donald G Guiney; Nicholas J Webster; David H Broide; Allen F Ryan; Stephen I Wasserman
Journal:  J Infect Dis       Date:  2008-12-15       Impact factor: 5.226

Review 4.  Mouse models for the study of mucosal vaccination against otitis media.

Authors:  Albert Sabirov; Dennis W Metzger
Journal:  Vaccine       Date:  2008-02-04       Impact factor: 3.641

Review 5.  Mouse models for human otitis media.

Authors:  Dennis R Trune; Qing Yin Zheng
Journal:  Brain Res       Date:  2009-03-06       Impact factor: 3.252

Review 6.  Innate Immunity: Orchestrating Inflammation and Resolution of Otitis Media.

Authors:  Arwa Kurabi; Kwang Pak; Allen F Ryan; Stephen I Wasserman
Journal:  Curr Allergy Asthma Rep       Date:  2016-01       Impact factor: 4.806

Review 7.  What have we learned from murine models of otitis media?

Authors:  Hayley E Tyrer; Michael Crompton; Mahmood F Bhutta
Journal:  Curr Allergy Asthma Rep       Date:  2013-10       Impact factor: 4.806

Review 8.  [The role of innate immunity in otitis media].

Authors:  M Wigand; T K Hoffmann; A F Ryan; B Wollenberg; A Leichtle
Journal:  HNO       Date:  2018-06       Impact factor: 1.284

9.  TLR4-mediated induction of TLR2 signaling is critical in the pathogenesis and resolution of otitis media.

Authors:  Anke Leichtle; Michelle Hernandez; Kwang Pak; Kenshi Yamasaki; Chun-Fang Cheng; Nicholas J Webster; Allen F Ryan; Stephen I Wasserman
Journal:  Innate Immun       Date:  2009-07-08       Impact factor: 2.680

10.  The toll-Like receptor adaptor TRIF contributes to otitis media pathogenesis and recovery.

Authors:  Anke Leichtle; Michelle Hernandez; Kwang Pak; Nicholas J Webster; Stephen I Wasserman; Allen F Ryan
Journal:  BMC Immunol       Date:  2009-08-05       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.